compound
PE-22-28 (10mg Vial) Questions Answered
PE-22-28 is a synthetic heptapeptide (sequence: GVSWGLR) derived from the sortilin propeptide, engineered as a potent and selective antagonist of TREK-1 potassium channels [4] .
PE-22-28 (10mg Vial)
Week Daily Dose (µg) Units (per injection) (mL) Weeks 1–2 50 µg 1.5 units (0.015 mL) Weeks 3–4 100 µg 3 units (0.03 mL) Weeks 5–8 100 µg 3 units (0.03 mL) Weeks 9–12 (Optional) 150 µg 4.5 units (0.045 mL) Weeks 13–16 (Optional) 200 µg 6 units (0.06 mL) Freq...
PE-22-28 is a synthetic heptapeptide (sequence: GVSWGLR) derived from the sortilin propeptide, engineered as a potent and selective antagonist of TREK-1 potassium channels [4] .
Week Daily Dose (µg) Units (per injection) (mL) Weeks 1–2 50 µg 1.5 units (0.015 mL) Weeks 3–4 100 µg 3 units (0.03 mL) Weeks 5–8 100 µg 3 units (0.03 mL) Weeks 9–12 (Optional) 150 µg 4.5 units (0.045 mL) Weeks 13–16 (Optional) 200 µg 6 units (0.06 mL) Freq...
Plan based on an 8–16 week daily protocol with gradual titration. Replace vials every 4 weeks to maintain potency.
Proper storage preserves peptide quality and potency. Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.